Associate Professor, College of Pharmaceutical Sciences Dayananda Sagar University, India
Assoc. Prof. Dr. Prashant Tiwari is an accomplished researcher and educator in pharmacy with over a decade of teaching and research experience. He specializes in neuropharmacology, focusing on the use of plant-based formulations to manage neurodegenerative disorders and hyperprolactinemia. Dr. Tiwari has guided multiple postgraduate and doctoral research projects and actively contributes to academic committees. He is a member of prominent professional organizations, including the International Society of Neurochemistry and the Association of Pharmaceutical Teachers of India.
Profile
Scopus
Orcid
Education
Dr. Prashant Tiwari earned his Ph.D. in Pharmacy from Siksha O Anusandhan University, Bhubaneswar, in 2019. His doctoral research focused on managing hyperprolactinemia caused by neuroleptic drugs using selected plants. He completed his M. Pharm in Pharmacology from the same university in 2010, achieving a 7.26 CGPA (1st Class). Dr. Tiwari also holds a Professional Diploma in Clinical Research (PDCR) from Catalyst Clinical Services, New Delhi (2018), and a Post-Graduation Diploma in Computer Application (PGDCA) from Dr. C.V. Raman University, Bilaspur (2014). His undergraduate education was completed with a B. Pharm from the SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Central University, Bilaspur, in 2008.
Professional Experience
Dr. Tiwari is currently an Associate Professor at Dayananda Sagar University, Bengaluru, a role he has held since November 2022. Previously, he served as an Assistant Professor at the same institution (2021-2022) and Arka Jain University, Jamshedpur (2019-2021). Additionally, he worked as a Senior Research Fellow (2016-2019) at Siksha O Anusandhan University. His early career included positions as Assistant Professor at Royal College of Pharmacy, Raipur (2014-2016), and School of Pharmacy, CEC, Bilaspur (2011-2014).
Research Interests
Dr. Tiwari’s research interests include neuropharmacology, phytopharmacology, and the evaluation of natural compounds for treating neurodegenerative and metabolic disorders. His work focuses on drug-induced dyskinesia, neuroprotective effects of plant-based formulations, and computational drug design using artificial intelligence for various therapeutic applications.
Authorship Metrics
Dr. Tiwari has supervised numerous research projects at both the M. Pharm and Ph.D. levels, resulting in impactful contributions to neuropharmacology and drug discovery. He has participated in several faculty development programs and short-term training initiatives sponsored by AICTE, focusing on innovative research methodologies and teaching practices.
Publications
1. BACE1 Inhibitors for Alzheimer’s Disease
- Citation: Arya, R., Jain, S., Paliwal, S., Tiwari, P., Kadiri, S.K., Asian Pacific Journal of Tropical Biomedicine, 2024, 14(9), pp. 369–381
- Key Highlights: This article reviews the potential of BACE1 inhibitors as a therapeutic approach for managing Alzheimer’s disease. The focus on BACE1 (beta-secretase 1) highlights its role in reducing amyloid beta production, which is crucial in the pathogenesis of Alzheimer’s. It seems to be a promising area for new drug development.
- Relevance: This review article contributes to the growing field of neurodegenerative disease management by summarizing advancements in BACE1-targeting therapies.
2. Software and Programming Tools in Pharmaceutical Research (Book)
- Citation: Singh, D., Tiwari, P., Software and Programming Tools in Pharmaceutical Research, 2024, pp. 1–318
- Key Highlights: This book appears to focus on the application of software tools in pharmaceutical research. Likely topics include computational drug design, pharmacokinetics modeling, and data analysis.
- Relevance: It serves as a comprehensive guide for integrating programming tools in drug discovery and research. Researchers using computer-aided drug development (CADD) would find this resource beneficial.
3. Preface to Pharmaceutical Research Tools (Editorial)
- Citation: Singh, D., Tiwari, P., Software and Programming Tools in Pharmaceutical Research, 2024, pp. i
- Key Highlights: Provides context and an overview of the book’s objectives, emphasizing the importance of computational tools in modern pharmaceutical research.
- Relevance: While the preface is not cited frequently, it sets the stage for understanding the book’s contributions.
4. Screening Software for Herbal Drug Interactions (Book Chapter)
- Citation: Kadiri, S.K., Tiwari, P., Software and Programming Tools in Pharmaceutical Research, 2024, pp. 207–226
- Key Highlights: Focuses on advanced screening tools for identifying interactions in herbal drugs. This likely involves predictive modeling and simulations.Relevance: This chapter addresses the need for specialized software to study the complex pharmacodynamics of herbal medicines.
5. Quantum-Inspired Macromolecular Design for Drug Delivery
- Citation: Singh, D., Bhattacharya, S., Tiwari, P., Journal of Macromolecular Science, Part B: Physics, 2024
- Key Highlights: Discusses the use of quantum dots in enhancing polymer functionality, particularly for targeted drug delivery. Quantum-inspired designs aim to improve the precision and efficacy of drug delivery systems.
- Relevance: Cutting-edge research combining quantum physics and macromolecular science to address challenges in pharmacology. Likely of interest to specialists in nanomedicine and polymer science.
Conclusion
Dr. Prashant Tiwari is a strong candidate for the Excellence in Research award due to his contributions to neuropharmacology, innovative use of technology in drug design, and dedication to academic mentorship. His work aligns well with the award’s criteria, particularly his focus on impactful, plant-based therapeutic approaches for neurodegenerative disorders.
To strengthen his candidacy further, Dr. Tiwari could emphasize his research’s global impact, expand international collaborations, and highlight quantitative measures of his influence, such as citation metrics and funded projects. Overall, he presents a compelling case for recognition in his field.